Filter by: patients

Sort by: Helpfulness | Most Recent

1 patient evaluation for Adalimumab taken for the purpose of 'Crohn's Disease' with a side effects rating of NoneNoneNoneNoneNone

Purpose: Crohn's Disease (Started Apr 13, 2011)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Apr 22, 2011 20 mg/0.4 mL Every Other Week ?Can't tell NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
  • Icon_thumb_off 0 helpful marks

3 additional evaluations for Adalimumab are not currently shared publicly.